CareDx (CDNA) | Stock Overview & Key Data
CareDx Performance Comparison
Stock Range
Today's Range
Low: $12.28
High: $13.04
on August 22, 2025
52 Week Range
Low: $10.96
High: $33.21
on July 17, 2025
on August 22, 2024
All-Time High: $99.83 on January 18, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$665.9M
EPS
1.05
P/E Ratio (TTM)
11.91
Forward P/E
21.57
P/B Ratio
2.03
PEG Ratio
0.03
Div. Yield
N/A
ROE
19.64%
Beta
2.221
Debt to Equity
8.90
Financial Highlights
Profitability
Gross Margin
66.94%
Operating Margin
-12.43%
Profit Margin
17.06%
Returns and Earnings
Return on Assets (TTM)
-5.85%
Return on Equity (TTM)
19.64%
EBITDA
$-28.5M
Net Income (TTM)
$58.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$6.22
Quarterly Revenue Growth (YoY)
-6.10%
Quarterly Earnings Growth (YoY)
-6.06%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| CareDx CDNA | 665.87M Small-cap | 9.54% | -0.38% | -24.20% | -39.31% | -39.73% | -58.91% | -37.90% | -61.89% |
| Thermo Fisher TMO | 184.10B Large-cap | 2.25% | 16.93% | 24.85% | -6.64% | -4.32% | -17.51% | -11.30% | 17.79% |
| Danaher DHR | 151.04B Large-cap | 0.41% | 11.53% | 12.97% | 0.31% | -7.84% | -21.40% | -14.78% | 16.18% |
| Twist Bioscience TWST | 1.69B Small-cap | 1.71% | -20.18% | 1.56% | -30.58% | -36.88% | -34.52% | -33.67% | -58.54% |
| Neogen NEOG | 1.22B Small-cap | 3.87% | 12.35% | -8.89% | -45.87% | -52.76% | -66.39% | -73.43% | -85.14% |
| Grail GRAL | 1.13B Small-cap | 5.58% | -7.86% | -11.68% | -24.42% | 91.07% | 122.19% | 134.20% | 134.20% |
Ownership & Short Interest
Insider Ownership
3.43%
Institutional Ownership
101.62%
Shares Short
6M
Short Ratio
3.04
Short % of Shares Outstanding
11.89%
Average 10-Day Volume
1M
Average 90-Day Volume
2M
CareDx Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in CareDx would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CDNA's 52-week high and low?
- In the last 52 weeks, CareDx reached a high of $33.21 (on August 22, 2024) and a low of $10.96 (on July 17, 2025).
- What is the market cap and P/E ratio for CDNA?
- Curious about CareDx's size and valuation? Its market capitalization stands at 665.87M. When it comes to valuation, the P/E ratio (trailing twelve months) is 11.91, and the forward P/E (looking ahead) is 21.57.
- Does CDNA pay dividends? If so, what's the yield?
- As for dividends, CareDx isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are CareDx's main competitors or similar companies to consider before investing?
When looking at CareDx, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO184.10B Healthcare Diagnostics & Research -17.51% -11.30% Danaher
DHR151.04B Healthcare Diagnostics & Research -21.40% -14.78% Twist Bioscience
TWST1.69B Healthcare Diagnostics & Research -34.52% -33.67% Neogen
NEOG1.22B Healthcare Diagnostics & Research -66.39% -73.43% Grail
GRAL1.13B Healthcare Diagnostics & Research 122.19% 134.20% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for CareDx Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of CareDx's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.64%, the Debt to Equity ratio from the most recent quarter is 8.90, and its Gross Profit Margin stands at 66.94%.
- What is the recent revenue and earnings growth for CDNA?
- Looking at CareDx's growth, its revenue over the trailing twelve months (TTM) was $341M. Compared to the same quarter last year (YoY), quarterly revenue grew by -6.10%, and quarterly earnings saw a YoY growth of -6.06%.
- How much of CDNA stock is held by insiders and institutions?
- Wondering who owns CareDx stock? Company insiders (like executives and directors) hold about 3.43% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 101.62%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.